Shree Hari Chemicals Export Ltd: Q1 FY27 Results

Shree Hari Chemicals Export Ltd reported a net profit of Rs 5.92 crore for the quarter ended June 30, 2026, compared to a net loss of Rs 1.67 crore in the same period last year. Revenue from operations rose to Rs 54.91 crore from Rs 24.32 crore.

Reader Takeaway: Strong profit turnaround and revenue growth in Q1 FY27; monitor impact of convertible debenture conversion.

What just happened

Shree Hari Chemicals Export Ltd announced its unaudited consolidated financial results for the first quarter of fiscal year 2027 (ended June 30, 2026). The company achieved a net profit of Rs 5.92 crore, a significant improvement from a net loss of Rs 1.67 crore in the corresponding quarter of the previous fiscal year. Consolidated revenue from operations increased substantially to Rs 54.91 crore, up from Rs 24.32 crore in the prior year's quarter.

Why this matters

The return to profitability and robust revenue growth signal a positive operational performance and potential turnaround for the company. This financial performance is crucial for investor confidence and demonstrates the company's ability to generate earnings. The confirmed full utilization of preferential issue funds also addresses potential governance concerns.

The backstory

The company had previously raised funds through a preferential issue. Additionally, on November 15, 2024, Shree Hari Chemicals allotted 18,66,580 Zero Coupon Compulsorily Convertible Debentures (CCDs). A portion of these, 7,74,946 CCDs, were converted into equity shares on April 3, 2026.

What changes now

The strong financial results and clear utilization of funds are positive indicators. The conversion of CCDs into equity shares will impact the company's equity structure and potentially future Earnings Per Share (EPS) calculations. Investors will be keen to see how this capital base change affects future profitability metrics.

Risks to watch

While the current results are positive, investors should monitor the dilution effect of the CCD conversion on EPS and the company's ability to sustain this growth trajectory in the coming quarters. The effective management of working capital and market conditions for chemical exports remain key.

Peer comparison

(No verifiable peer comparison data available in the provided filing.)

Context metrics (time-bound)

• Revenue Growth (YoY): 125.8% increase to Rs 54.91 crore (Q1 FY27 vs Q1 FY26)
• Profitability Shift: From a net loss of Rs 1.67 crore (Q1 FY26) to a net profit of Rs 5.92 crore (Q1 FY27)
• EPS: Improved from (Rs 3.39) to 9.41 (Q1 FY27 vs Q1 FY26)

What to track next

Investors should closely watch the company's subsequent quarterly results to confirm if this performance is sustainable. Monitoring the impact of the expanded equity base on EPS and any further corporate actions will be important.